BMY 45778
BMY 45778 is a non-prostanoid prostacyclin mimetic. BMY 45778 inhibits human (IC50 = 35 nM), rabbit (IC50: 136 nM) and rat (IC50 : 1.3 μM) platelet aggregation. BMY 45778 also activates adenylyl cyclase. BMY 45778 is a partial agonist at the prostacyclin receptor[1].
Product Specifications
CAS Number
152575-66-1
UNSPSC
12352005
Target
Adenylate Cyclase; Prostaglandin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/bmy-45778.html
Purity
98.98
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(O)COC1=CC=CC(C2=C(C3=NC(C4=CC=CC=C4)=C(C5=CC=CC=C5)O3)N=CO2)=C1
Molecular Formula
C26H18N2O5
Molecular Weight
438.43
References & Citations
[1]Seiler SM, et al. [3-[4- (4,5-Diphenyl-2-oxazolyl) -5-oxazolyl]phenoxy]acetic acid (BMY 45778) is a potent non-prostanoid prostacyclin partial agonist: effects on platelet aggregation, adenylyl cyclase, cAMP levels, protein kinase, and iloprost binding. Prostaglandins. 1997 Jan;53 (1) :21-35.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-E741655-10MG 10 mg
Bis(2-aminoethyl)(nitroso)amine Dihydrochloride
Sign In for Pricing
View Details 